LinkedIn · Oct 2025
Varun Govil announced the first EpiAmp dataset and whitepaper, claiming >99% per-doubling accuracy, faithful 5mC preservation across millions of CpG sites, and compatibility with short-read, long-read, and PCR-based workflows.
We engineer proteins that control the operating system of biology.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Epinoma is a San Carlos-based biotechnology research / diagnostics company developing EpiAmp, a methyl-preserving, conversion-free amplification platform for DNA methylation analysis used in early cancer detection, MRD monitoring, and epigenetic therapeutics. Public funding records are inconsistent across databases, but the clearest source-backed announcement is a $3M seed financing led by SeedToB Capital.
Primary product
EpiAmp methyl-preserving amplification platform
Founded
2020
Headquarters
930 Brittan Avenue, San Carlos, CA 94070, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Epigenetic diagnostics
Offices
Open Positions
0 jobs at Epinoma
No open positions
Check back later for new openings